How much did Wellspent raise with this deck?

According to the catalogue listing, Wellspent raised $1.07M in a Seed round in 2022. The lead investor was Masawa, with participation from angels like Christian Rebernik and Ina Schlie. Interestingly, the deck itself (Slide 10) obscures the previous pre-seed amount with a placeholder '€x', suggesting this version was used during the transition to their Seed raise.

What is Wellspent's core product functionality?

The product, as described on Slide 4, follows a three-step process: identifying unhealthy habits through training, replacing them with bite-sized exercises and specialized courses, and providing real-time 'nudges.' These nudges detect when a user is distracted by their phone and provide an intervention to get them back on track.

What scientific evidence does Wellspent provide?

Wellspent leans heavily on a randomized controlled trial (RCT) conducted with the Freie Universität Berlin involving 232 participants. Slide 5 highlights four key outcomes: a 42% reduction in problematic smartphone use, a 20% reduction in screen time, an 8% increase in overall wellbeing, and a 40% decrease in impulsive habit strength.

Who are the competitors mentioned in the deck?

The deck does not feature a traditional competitive matrix. Instead, it maps the landscape by category on Slides 7 and 8. It lists 'Habit Building' apps like Fabulous and Forest, 'Habit Regulation' apps like Noom, and 'Habit Elimination' tools like Quit Genius and Pear Therapeutics, positioning Wellspent in the 'Screen Time Management' niche.

What is missing from the Wellspent pitch deck?

The deck is missing several standard components: a detailed financial forecast, a specific 'Ask' slide (amount and milestones), a roadmap of future features, and a clear explanation of the B2B business model mentioned in the catalogue. It relies almost entirely on the problem's scale and the product's proven efficacy to carry the narrative.

Wellspent Pitch Deck: All 13 Slides + Teardown

See all 13 slides of the Wellspent pitch deck — a 2022 Seed deck — with a slide-by-slide teardown of what the deck does well and where it falls short.

Wellspent’s 2022 Seed deck is a masterclass in using scientific validation to de-risk a consumer-facing healthcare app. By leading with a randomized controlled trial (RCT) conducted with the Freie Universität Berlin, the company moves beyond the 'wellness' category into 'digital therapeutics.' The deck identifies a massive $24 billion market opportunity based on an $81 Average Revenue Per Paying User (ARPPU) across 310 million affected individuals. While the deck is visually minimalist and lacks a detailed financial roadmap or specific 'Ask' slide, the strength of its team—featuring experienc…

Key takeaways

The company positions itself as an 'AI-coach for healthy technology use' on Slide 1.
A randomized controlled trial with 232 participants showed a 42% reduction in problematic smartphone use (Slide 5).
The deck claims 310 million people worldwide fail to stick to healthy phone habits (Slide 2).
Market potential is calculated at $24 billion based on 310 million affected users and an $81 ARPPU (Slide 8).
One premium subscriber reported reducing screen time from 7.5 hours per day to 2.5 hours (Slide 9).
The founding team includes a CTO with experience at Calm and Keepsafe, and a CEO who is a 2x founder (Slide 10).
The deck lacks a specific 'Ask' slide detailing the amount of capital sought or the planned use of funds.
The product uses real-time 'nudges' to interrupt users when they lose themselves in their phones (Slide 4).

The Scientific Approach to Digital Wellness

Wellspent (operating under the brand 'not less but better' at the time of this deck) entered the market during a period of intense scrutiny regarding 'The Attention Economy.' While many apps attempt to solve screen addiction through simple timers or blockers, Wellspent’s pitch deck focuses on behavioral psychology and clinical validation. This teardown examines how a 13-slide deck successfully navigated the transition from a wellness app to a digital health platform.

Slides 1-3: The Macro Problem

Slide 1 introduces the brand 'not less but better' and defines the product as an 'AI-coach for healthy technology use.' The imagery is clean, featuring a hand holding a smartphone with a soft, peach-toned UI. This immediately distances the product from 'punitive' screen blockers, suggesting a more supportive, coaching-based relationship.

Slide 2 quantifies the problem with staggering figures. It claims the average person spends 17 years on their phone during their lifetime, citing App Annie (2021). It also notes that 310 million people worldwide fail to stick to healthy phone habits. By linking over-use to 'stress, sleep deprivation and depression,' the deck establishes the 'Healthcare' sector classification early on.

Slide 3 serves as a transition, stating that in the current attention economy, a mental health crisis is 'inevitable' without a simple solution. It is a high-stakes claim designed to create urgency for the solution that follows.

Slides 4-5: The Solution and The Proof

Slide 4 breaks down the product into three pillars: Identify, Replace, and Nudge. The 'Nudge' feature is particularly notable as it is labeled 'Alpha.' It describes technology that detects when a user 'loses themselves' in their phone and provides a real-time intervention. This suggests a level of technical sophistication beyond standard iOS Screen Time settings.

Slide 5 is the 'money slide' for this deck. It presents the results of a Randomized Controlled Trial (RCT) with Freie Universität Berlin. For a Seed stage startup, having a study with 232 participants is a significant de-risking factor. The slide claims a 42% reduction in problematic smartphone use and a 20% reduction in screen time. In the world of digital health, clinical proof is the primary differentiator between a 'nice-to-have' app and a reimbursable medical tool.

Slides 6-8: Market Dynamics and Opportunity

Slide 6 focuses on 'Why Now.' It highlights that mindfulness consumer spending has increased 24.3x to $195M/year since 2015 and that $1.5bn was funded for US-based mental health companies in 2020 alone. This slide is intended to show that the 'Digital Well-being' space is no longer a niche interest but a venture-scale category.

Slide 7 uses a 'Potential' framework to compare Wellspent to other billion-dollar apps. It lists Coursera ($5bn), Calm ($2bn), and Noom ($4bn). By placing Wellspent in the same context as these giants, the founders are signaling their ambition to move from a simple app to a platform-level company.

Slide 8 provides the actual TAM (Total Addressable Market) calculation. They estimate a $24bn market potential. This is derived from the 310 million affected individuals multiplied by an $81 ARPPU (Average Revenue Per Paying User). This is a bold figure, as $81 is a high price point for a consumer app, suggesting they are either targeting high-intent users or looking toward B2B/employer-sponsored models.

Slides 9-13: Traction, Team, and Vision

Slide 9 is a simple testimonial from a premium subscriber who reduced their screen time from 7.5 hours to 2.5 hours. While anecdotal, it puts a human face on the 20% reduction metric mentioned earlier.

Slide 10 introduces the team. The pedigree is strong: Marius (CTO) has experience with Calm and Keepsafe; Christina (CPO) brings psychology and design thinking from Bosch and DB; Selcuk (CEO) is a 2x founder. The slide also mentions '6 Add. Team Members' with experience at Blinkist and The New York Times. This slide effectively communicates that the team has the 'product-market fit' experience required to scale a consumer app.

Slide 11 and Slide 12 close the deck with a vision statement: 'We are redistributing attention... back to the owners: the people.' Slide 12 provides a contact for Christina Roitzheim and a call to action to 'Join us.'

What Wellspent Does Well

The strongest element of this deck is the Clinical Validation . Most wellness startups rely on 'vibe-based' marketing. Wellspent’s reliance on a Randomized Controlled Trial (RCT) on Slide 5 immediately elevates the conversation from 'we have a cool app' to 'we have a proven intervention.' This is likely what attracted Masawa, an impact fund focused on mental wellness.

The Market Mapping on Slide 8 is also highly effective. Instead of a standard 'X/Y' axis chart where the startup is magically in the top-right corner, they categorize the market by 'Habit Building,' 'Habit Regulation,' and 'Habit Elimination.' This shows a sophisticated understanding of the behavioral change landscape.

What is Missing from the Wellspent Deck

The Business Model: While the catalogue listing identifies this as a B2B model, the deck is almost entirely focused on the consumer experience and the 'App Store' review. There is no mention of how they sell to enterprises, what the B2B pricing looks like, or if they have any corporate pilots in progress.

The Financials and Ask: The deck is remarkably light on numbers. There is no slide showing current MRR (Monthly Recurring Revenue), churn rates, or CAC (Customer Acquisition Cost). Furthermore, there is no 'Ask' slide. Investors usually want to see exactly how much is being raised and what milestones that capital will unlock over the next 18-24 months.

The Roadmap: The 'Nudge' technology is mentioned as being in 'Alpha,' but there is no timeline for when this or other AI-driven features will be fully integrated. This leaves a gap in the 'Product' narrative.

What Founders Should Copy

The 'Proof' Slide: If you have any data that resembles a clinical trial or a large-scale user study, make it the centerpiece of your deck. Wellspent’s Slide 5 is the reason they raised $1M+.

Minimalist Design: The deck uses a consistent color palette and avoids cluttered slides. This makes the heavy data points (like the 17 years spent on phones) stand out more effectively.

The 'Why Now' Context: Slide 6 does a great job of linking a specific startup to a broader economic trend (the explosion of mental health funding). It makes the startup feel like an inevitable part of a larger movement rather than an isolated project.

Final Thoughts

Wellspent’s deck is a 'Signal' deck. It doesn't provide the 'Noise' of complex financial modeling or long feature lists. Instead, it provides three high-strength signals: a massive, painful problem; a scientifically proven solution; and a team that has built similar products before. For a Seed round, those three signals are often more persuasive than a 30-slide deck full of unproven projections.

Frequently asked questions

How much did Wellspent raise with this deck?: According to the catalogue listing, Wellspent raised $1.07M in a Seed round in 2022. The lead investor was Masawa, with participation from angels like Christian Rebernik and Ina Schlie. Interestingly, the deck itself (Slide 10) obscures the previous pre-seed amount with a placeholder '€x', suggesting this version was used during the transition to their Seed raise.
What is Wellspent's core product functionality?: The product, as described on Slide 4, follows a three-step process: identifying unhealthy habits through training, replacing them with bite-sized exercises and specialized courses, and providing real-time 'nudges.' These nudges detect when a user is distracted by their phone and provide an intervention to get them back on track.
What scientific evidence does Wellspent provide?: Wellspent leans heavily on a randomized controlled trial (RCT) conducted with the Freie Universität Berlin involving 232 participants. Slide 5 highlights four key outcomes: a 42% reduction in problematic smartphone use, a 20% reduction in screen time, an 8% increase in overall wellbeing, and a 40% decrease in impulsive habit strength.
Who are the competitors mentioned in the deck?: The deck does not feature a traditional competitive matrix. Instead, it maps the landscape by category on Slides 7 and 8. It lists 'Habit Building' apps like Fabulous and Forest, 'Habit Regulation' apps like Noom, and 'Habit Elimination' tools like Quit Genius and Pear Therapeutics, positioning Wellspent in the 'Screen Time Management' niche.
What is missing from the Wellspent pitch deck?: The deck is missing several standard components: a detailed financial forecast, a specific 'Ask' slide (amount and milestones), a roadmap of future features, and a clear explanation of the B2B business model mentioned in the catalogue. It relies almost entirely on the problem's scale and the product's proven efficacy to carry the narrative.

Cover slide of the Wellspent (formerly not less but better) pitch deck — Seed 2022 — Wellspent (formerly not less but better) pitch deck, slide 1 (2022)

Wellspent (formerly not less but better) pitch deck: the facts

Company: Wellspent (formerly not less but better)
Year: 2022
Stage: Seed
Slides: 13
Sector: Healthcare / Digital Well-being
Deck type: Pitch Deck
Outcome: $1.07M Raised
Headquarters: Berlin, Germany

Wellspent (formerly not less but better) pitch deck PDF

The full Wellspent (formerly not less but better) deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Wellspent (formerly not less but better) pitch deck was used for

This is Wellspent’s 13‑slide **seed pitch deck from 2022** for a digital wellbeing app tackling problematic smartphone use and phone addiction. The company was previously branded **not less but better**, an anti‑phone‑addiction startup offering daily micro‑training based on cognitive behavioral therapy. Catalogue/tracking sources list this round as a **Seed raise of about $1.07M in 2022**, following a roughly **€940k pre‑seed round** publicized under the not less but better brand. The deck leans on a randomized controlled trial of the Wellspent app to argue that its clinically‑tested training and in‑the‑moment nudges can significantly reduce problematic smartphone use and screen time.

Round: Seed
Year: 2022
Lead investor: Masawa
Investors: Masawa (lead investor as tracked by funding databases), Christian Rebernik (named angel investor in trackers)
Industry: Digital wellbeing / health technology

Raised: $1.07M (Seed round, June 1, 2022, per funding trackers and pitch‑deck catalogue)

Total funding: Approximately €940k pre-seed plus $1.07M seed (catalogue/tracking sources)

What happened after the Wellspent (formerly not less but better) deck

Following an initial pre‑seed raise under the not less but better brand, Wellspent secured a Seed round of about $1.07M in 2022 and contributed its app to randomized controlled trials with German university partners, which showed significant reductions in problematic smartphone use and daily usage of problematic social media apps. The public record focuses more on research outputs and funding even

Completion of randomized controlled trials evaluating the Wellspent app’s impact on problematic smartphone use and socia
Publication of peer‑reviewed articles in digital health journals (e.g., JMIR mHealth and uHealth) reporting significant
Completion of at least one Seed funding round around June 2022, with Masawa tracked as lead investor and approximately $

What the Wellspent (formerly not less but better) deck got right

Robust clinical evidence supporting efficacy. The deck centers on a **randomized controlled trial** of the Wellspent app with hundreds of participants, reporting a **42% reduction in problematic smartphone use**, about **20% less screen time**, and improvements in wellbeing and impulsive habit strength; this level of quantified behavioral evidence is rare among consumer wellbeing apps and strongly supports efficacy claims.
Clear, behaviorally grounded product story. Slides describe a clear three‑step user journey: **identifying unhealthy phone habits**, replacing them with **bite‑sized exercises and specialized courses**, and employing **real‑time nudges** when users lose themselves in their phones, which creates a coherent, behavior‑change‑oriented product narrative investors can easily understand.
Strong alignment with academic health‑psychology research. The deck leverages the founder team’s collaboration with university‑based health‑psychology researchers and published RCTs in recognized journals (e.g., JMIR mHealth and uHealth), which positions Wellspent as a **clinical‑first digital wellbeing company** rather than a generic productivity app.
Compelling, relatable user impact story. Including a concrete testimonial (“reduced screen time from 7.5 hours to 2.5 hours per day and became more productive and focused”) provides an intuitive, outcome‑oriented anecdote that complements the numerical trial results and makes the problem and solution relatable.
Differentiated real‑time nudging technology. The deck references Wellspent’s ability to **detect when users lose themselves in their phones** and deliver autonomy‑supportive, in‑the‑moment nudges—an approach that later research posts describe as reducing usage of the most problematic app by about 29 minutes per day, reinforcing the deck’s claim that real‑time behavioral interventions are central to the product’s value.
Demonstrated ability to secure multiple funding rounds. Public sources show a **pre‑seed round under the not less but better brand and a 2022 Seed round for Wellspent**, indicating that the team has already convinced multiple investors and that the deck was effective enough to accompany a seven‑figure raise.

What could have been stronger

Limited methodological transparency around the clinical trial. The deck is described as heavily emphasizing clinical outcomes but does not (in public commentary or OCR) show **trial design details, effect sizes vs control, or limitations**; investors must rely on secondary summaries of the RCT rather than seeing methodology and robustness transparently laid out in the slides.
Clinical evidence appears stronger than commercial traction evidence. Catalogue and teardown commentary describe high‑level outcomes like **42% reduction in problematic smartphone use and 20% less screen time**, but there is no public evidence that the deck provides **commercial traction metrics** (paying users, retention, cohorts, or revenue) alongside the clinical data. This may leave investors unsure about market validation beyond the research study.
Potential selectivity in how trial results are summarized. External sources show nuanced trial results (e.g., reductions in problematic smartphone use and usage of the most problematic app, but no significant change in problematic social media use or self‑efficacy). If the deck only highlights the headline benefits, it risks being seen as **selective about which results are presented**, raising questions about how fully the evidence is represented.
Funding story may be imprecise or fragmented. Secondary funding trackers disagree slightly on total funding figures and do not consistently list all investors or round structures. If the deck mirrors these high‑level numbers without clarifying exact instruments, currencies, and cap‑table impact, investors may perceive a **lack of precision in financing narrative**.

How an investor would read this deck

What draws attention

How the Wellspent app translates **clinical outcomes (42% reduction in problematic smartphone use, 20% less screen time)** into sustainable user engagement, subscription revenue, and enterprise or insurer partnerships.
Whether the **RCT population and setting** (university‑affiliated participants in Germany) match the company’s target commercial market and whether similar results can be reproduced in broader, less motivated populations.
The **competitive landscape in digital wellbeing and screen‑time management**, including OS‑level screen‑time tools, behavioral‑health apps, and coaching solutions; investors will look for differentiation beyond CBT micro‑training and nudges.
Quality and reproducibility of the **clinical trial**, including adherence, drop‑out rates, effect sizes vs active or wait‑list controls, and whether the trial was sponsored solely by academic budgets rather than the company.
Details of Wellspent’s **funding history** (pre‑seed under not less but better and 2022 seed round) and current runway, given that public trackers show multiple entries and slightly differing totals.

Risks that stand out

The **clinical evidence base**, while promising, may be limited to specific populations and show mixed results on some endpoints (e.g., no significant change in problematic social media use or self‑efficacy), raising risk that commercial impact will be lower than headline figures suggest.
The market for **digital wellbeing and screen‑time management** is crowded and includes OS‑level tools and large consumer apps, so acquisition costs may be high and differentiation based solely on CBT micro‑training and nudges may be challenging.
If most of the company’s narrative and valuation are anchored on the initial RCT, future investors may view the company as **research‑heavy but commercially under‑validated** unless robust traction data emerge.
Funding trackers show multiple rounds and differing totals, and there is limited public information on revenue; this creates uncertainty about **runway, capital efficiency, and future financing needs**.

Questions this deck invites

Please provide the **full RCT protocol, statistical analysis plan, and published paper** for the Wellspent trial, including all primary and secondary endpoints and effect sizes vs control groups.
How many **active users**, paying subscribers, and enterprise clients** does Wellspent currently have, and what are the key retention, cohort usage, and churn metrics over 3, 6, and 12 months? (No such metrics are cited in the publicly avai
What is the **pricing model** (B2C subscription, B2B2C via employers/insurers, or hybrid), and how does this align with the populations in which the RCT showed efficacy?
How has the product evolved since the RCT (feature changes, nudging algorithms, personalization) and have you conducted any **post‑market observational studies** to validate that similar reductions in problematic smartphone use and screen t
Can you clarify the **relationship between not less but better and Wellspent** (legal entity continuity, ownership, capitalization) and reconcile the different funding numbers (≈€940k pre‑seed and $1.07M seed) shown in trackers and deck com

What founders can take from the Wellspent (formerly not less but better) deck

Anchoring a digital wellbeing pitch deck in a **randomized controlled trial** with quantified behavioral outcomes can strongly differentiate the product from generic self‑help apps and increase credibility with impact‑oriented investors.
Explicitly tying **clinical metrics** (e.g., reductions in problematic smartphone use and screen time) to the product’s core features—habit identification, CBT‑style micro‑training, and in‑the‑moment nudges—helps investors see a causal path from intervention design to measurable outcomes.
Using a relatable **user testimonial** about cutting daily screen time from 7.5 to 2.5 hours and improving productivity makes the abstract problem of phone addiction tangible and helps humanize the impact story.
Leveraging prior funding and brand history (not less but better’s pre‑seed raise and CBT focus) in a new deck can show **continuity of vision** and validate that the team has been working on the problem for several years.
At the same time, a clinically‑heavy deck without clear **commercial traction metrics** highlights the importance of balancing scientific validation with evidence of market demand, monetization, and scalability.
Maintaining consistency between **published research results and deck claims** is crucial; any perception of selective reporting or over‑emphasis on positive endpoints can trigger deeper investor diligence into the evidence quality.

Wellspent (formerly not less but better) pitch deck: common questions

How much did Wellspent raise in the Seed round associated with this deck, and were there prior rounds?

According to catalogue listings and deck commentary, Wellspent raised **about $1.07M in a Seed round in 2022**, with Masawa listed as lead investor and approximately 14 investors participating. A prior **€940k (about $1M) pre‑seed round** was reported for the company under its earlier brand name, not less but better.

What stage and timing was the Wellspent round that this pitch deck supported?

Tracking sources and pitch‑deck commentary describe the round as **Seed**, dated **June 1, 2022**, with a post‑money valuation of about **$3.29M**. This aligns with the deck being catalogued as a **2022, Seed, 13‑slide healthcare / digital wellbeing pitch deck**.

What does Wellspent (formerly not less but better) actually do?

Business‑insider coverage and data sources link **Wellspent** to the earlier brand **not less but better**, described as a digital‑wellness startup offering daily micro‑training based on cognitive behavioral therapy for phone addiction and unhealthy screen behaviors. The Wellspent deck continues this focus, presenting an app that identifies unhealthy smartphone habits, trains replacement habits via bite‑sized and specialized courses, and uses real‑time nudges when users lose themselves in their phones.

What clinical evidence does the Wellspent deck rely on for its claims about reducing phone addiction?

A randomized controlled trial conducted with German university researchers evaluated the **Wellspent app** as a customizable intervention tool targeting problematic social media app use. Pitch‑deck analysis reports that the study had **232 participants** and found a **42% reduction in problematic smartphone use**, around **20% less screen time**, improvements in wellbeing, and reduced impulsive habit strength. A later JMIR mHealth and uHealth paper and linked trial registration describe significant reductions in daily use of the most problematic app and perceived problematic smartphone use, with no significant changes in problematic social media use or self‑efficacy.

Who invested in Wellspent’s Seed round, and is Masawa actually the lead investor?

Catalogue and tracking entries list **Masawa** as lead investor in the June 2022 Seed round, alongside named angel Christian Rebernik and a broader group of about 12 additional investors. Public journalism on the earlier pre‑seed round does not list all investors but notes the company’s digital‑wellness positioning and CBT‑based training approach. Specific cap‑table details beyond those names are not publicly disclosed in primary filings or press, so only Masawa and Christian Rebernik can be cited from secondary data sources.

Sources

Funding and outcome facts on this page were researched on 2026-08-21 from the pages below.

Wellspent (formerly not less but better) pitch deck slides

Wellspent (formerly not less but better) pitch deck slide 1 of 13 — Wellspent (formerly not less but better) pitch deck — slide 1 of 13

Wellspent (formerly not less but better) pitch deck slide 2 of 13 — Wellspent (formerly not less but better) pitch deck — slide 2 of 13

Wellspent (formerly not less but better) pitch deck slide 3 of 13 — Wellspent (formerly not less but better) pitch deck — slide 3 of 13

Wellspent (formerly not less but better) pitch deck slide 4 of 13 — Wellspent (formerly not less but better) pitch deck — slide 4 of 13

Wellspent (formerly not less but better) pitch deck slide 5 of 13 — Wellspent (formerly not less but better) pitch deck — slide 5 of 13

Wellspent (formerly not less but better) pitch deck slide 6 of 13 — Wellspent (formerly not less but better) pitch deck — slide 6 of 13

What each slide of the Wellspent (formerly not less but better) pitch deck says

Slide 1

<2 \- — not less - SBA a Ta but better - Al-coach for healthy technology use

Slide 2

Phone over-users fail to build . : healthy habits, leading to 3 \ massive harm for well-being ” { »% S 2 : & ’

Slide 3

Bt betier In the current attention economy, a mental health crisis is inevitable without a simple and effective solution against phone addiction.

Slide 4

nottes SoLuTION Bt better We help over-users overcome unhealthy phone habits Identify unhealthy habits Replace them with good habits Get nudged in e Scientifically-proven training Bite-sized exercises & specialized Our technology defects when you concept fo significantly improve courses with practical fools fo frain lose yourself in your phone, and screen habits and well-being. your habit strength gently nudges you back on frack. ) o

Slide 5

not less. SCIENTIFIC EVIDENCE but better s First RCT-approved app to create significant outcomes for healthy habits Tm Randomized controlled trial with the Freie Universitat - sohone Use Berlin and 232 participants, problematic Smariprs outcomes: EE g -42%° E / Reduction of problematic (i) smariphone use 5 -20%"* Ji & Reduction of screentime 2 z | +8%" " peforenibh Aer 3 weet “aes taining Increase of overall wellbeing io Decrease of habit strength (impulsive smartphone use)